NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

Cai, Qingqing; Tu, Meifeng; Xu-Monette, Zijun Y; Sun, Ruifang; Manyam, Ganiraju C; Xu, Xiaolu; Tzankov, Alexander; Hsi, Eric D; Møller, Michael B; Medeiros, L Jeffrey; Ok, Chi Young; Young, Ken H.
Mod Pathol; 30(6): 854-876, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28281555